| ORIGINAL ARTICLE |
|
| Year : 2013 | Volume
: 32
| Issue : 4 | Page : 217-221 |
|
|
Ethnomedicinal plants used by the Nag clan of the Rai Ghatual tribe of Moulvibazar district, Bangladesh
Protiva Rani Das, Md Tabibul Islam, Rownak Jahan, Mohammed Rahmatullah
Department of Biotechnology and Genetic Engineering, University of Development Alternative, Dhanmondi, Dhaka-1209, Bangladesh
Correspondence Address:
Mohammed Rahmatullah
Faculty of Life Sciences, University of Development Alternative, House 78, Road 11A, Dhanmondi, Dhaka - 1209
Bangladesh
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0257-7941.131975
|
|
|
Context: Medicinal practices of the tribes of Bangladesh remain largely un-documented.
Aims: The aim of the present study was to conduct an ethnomedicinal survey and documentation among the Nag clan of the Rai Ghatual tribe of Bangladesh.
Settings and Design: The survey was carried out among the Nag clan of the Rai Ghatual tribal community of Moulvibazar district. The clan, according to them, is the only Nag clan of the Rai Ghatual tribe in Bangladesh. The clan has three tribal healers, still continuing their traditional medicinal practices.
Materials and Methods: Interviews of the healers were carried out with the help of a semi-structured questionnaire and the guided field-walk method.
Results: The Nag clan healers were observed to use 28 different plant species distributed into 22 families for treatment of ailments such as fever, loss of appetite, male infertility, dysentery, lower abdominal pain during menstruation, jaundice, stomachache, burning sensations during urination, bodily pain and weak health.
Conclusions: This is the first reported study of the traditional medicinal practices of Nag clan healers. Several of the plants can be validated in their uses on the basis of existing scientific literature. The medicinal plants used by the Nag healers warrant further scientific studies, for the plants are readily available and can form alternative medicinal sources instead of costlier biomedical drugs. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
